Characteristics of published studies evaluating the associations of M. genitalium with vaginal discharge or urethritis.

1Cases are those individuals with defined signs or symptoms; controls are individuals without signs or symptoms.2M. genitalium prevalence and OR calculated at enrollment.3Cumulative, multi-sampling prevalence over a 5-y study that included M. genitalium PCR- and culture-positive individuals; only PCR-positive individuals considered for prevalence in cases vs. controls and OR calculations.4Excluded women co-infected with NG, CT, and TV.5Cumulative, multi-sampling prevalence.6Excluded patients co-infected with M. genitalium and CT.7OR calculated from symptoms reported at each sampling and excluded patients co-infected with M. genitalium and CT or NG.8Excluded patients with concurrent cervicitis.9For OR calculation and prevalence in cases versus controls, number of M. genitalium infections represented FVU-positive samples; overall prevalence for entire study population determined from FVU and endocervical swabs.MG, Mycoplasma genitalium; OR, odds ratio; RR, relative risk; HR, hazard ratio; pmn/hpf, polymorphonuclear leukocytes per high-power microscope field; STI, sexually transmitted infection; PHC, public health clinic; THC, teen health center; ER, emergency room; WH, women's health; FVU, first void urine; US, urethral swab; A, age; CT, Chlamydia trachomatis status; NG, Neisseria gonorrhoeae status; TV, Trichomonas vaginalis status; PS, pregnancy status, CA, Candida albicans status, BV, bacterial vaginosis status.